BrainStorm to Provide Corporate Update at the BIO International Convention

Wednesday, June 14, 2017 Corporate News
Email Print This Page Comment bookmark
Font : A-A+

HACKENSACK, N.J. and PETACH TIKVAH, Israel, June 14, 2017 /PRNewswire/ -- BrainStorm Cell

Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the Company will present a corporate overview at the BIO International Convention, taking place June
19-22
at the San Diego Convention Center in San Diego, California.

Presentation Details

Date:           Wednesday, June 21Time:           2:00pm Pacific TimePresenter:   Chaim Lebovits, Chief Executive Officer, BrainStorm Cell TherapeuticsLocation:     San Diego Convention Center, Company Presentation Theater 3Webcast:    http://www.veracast.com/webcasts/bio/internationalconvention2017/96236165162.cfm

About BrainStorm Cell Therapeutics Inc. BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult mesenchymal stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwnŽ technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University.  NurOwnŽ has been administered to approximately 75 patients with ALS in clinical trials conducted in the United States and Israel.  In a randomized, double-blind, placebo-controlled clinical trial conducted in the U. S., a clinically meaningful benefit was demonstrated by higher response to NurOwn compared with placebo.  For more information, visit the company's website at www.brainstorm-cell.com.

CONTACTS

Media: Uri YablonkaBrainstorm Cell Therapeutics Inc.Phone: (646) 666-3188uri@brainstorm-cell.com

Investors: Michael Rice LifeSci Advisors, LLCPhone: 646-597-6979mrice@lifesciadvisors.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/brainstorm-to-provide-corporate-update-at-the-bio-international-convention-300473770.html

SOURCE BrainStorm Cell Therapeutics Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook